SERPINB2 antibody (Middle Region)
-
- Target See all SERPINB2 Antibodies
- SERPINB2 (Plasminogen Activator Inhibitor 2 (SERPINB2))
-
Binding Specificity
- Middle Region
-
Reactivity
- Human, Rat, Mouse, Cow, Rabbit, Guinea Pig, Horse, Dog, Sheep
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This SERPINB2 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Sequence
- GKIPNLLPEG SVDGDTRMVL VNAVYFKGKW KTPFEKKLNG LYPFRVNSAQ
- Predicted Reactivity
- Cow: 86%, Dog: 100%, Guinea Pig: 92%, Horse: 93%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 85%, Sheep: 86%
- Characteristics
- This is a rabbit polyclonal antibody against SERPINB2. It was validated on Western Blot using a cell lysate as a positive control.
- Purification
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human SERPINB2
- Top Product
- Discover our top product SERPINB2 Primary Antibody
-
-
- Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
- Comment
-
Antigen size: 415 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma." in: Molecular cancer therapeutics, Vol. 6, Issue 1, pp. 203-12, (2007) (PubMed).
: "
-
Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma." in: Molecular cancer therapeutics, Vol. 6, Issue 1, pp. 203-12, (2007) (PubMed).
-
- Target
- SERPINB2 (Plasminogen Activator Inhibitor 2 (SERPINB2))
- Alternative Name
- SERPINB2 (SERPINB2 Products)
- Synonyms
- HsT1201 antibody, PAI antibody, PAI-2 antibody, PAI2 antibody, PLANH2 antibody, SERPINB2 antibody, Planh2 antibody, ovalbumin antibody, Pai2a antibody, serpin family B member 2 antibody, serpin peptidase inhibitor, clade B (ovalbumin), member 2 antibody, serine (or cysteine) peptidase inhibitor, clade B, member 2 antibody, SERPINB2 antibody, Serpinb2 antibody
- Target Type
- Amino Acid
- Background
-
SERPINB2 inhibits urokinase-type plasminogen activator. The monocyte derived PAI-2 is distinct from the endothelial cell-derived PAI-1.
Alias Symbols: HsT1201, PAI, PAI-2, PAI2, PLANH2
Protein Interaction Partner: UBC, APP, PRPF8, PSMB1, RBL2, RB1, IRF3, PLAU, SERPINB2,
Protein Size: 415 - Molecular Weight
- 44 kDa
- Gene ID
- 5055
- NCBI Accession
- NM_002575, NP_002566
- UniProt
- P05120
- Pathways
- Autophagy
-